The Experience and Reputation You Can Trust

Through a multidisciplinary team of industry, regulatory, and scientific specialists, Lachman Consultants helps organizations to prevent and resolve compliance problems and to develop efficient and effective strategies for the submission and approval of drugs, biologics, and devices. The company deploys only highly experienced consultants who consistently deliver top-quality results for a diverse base of global clients—including pharmaceutical biologic, biotechnology, medical device, and dietary supplement companies and the law firms that serve them. We specialize in the following:

Learn More About Lachman »

Impact of GDUFA FDA Webinar

Click HERE to Register for Webinar

Tuesday, Sept. 23, 2014 - 1:30 PM - 3:00 PM EDT

Practice Groups

COMPLIANCE... With a team of former industry and FDA seasoned specialists, Lachman's Compliance Practice stands ready to help you prevent and resolve complex challenges.

REGULATORY AFFAIRS... With former senior-level FDA managers, FDA reviewers, and industry specialists, Lachman's Regulatory Affairs Practice has the right knowledge and experience to recommend effective strategies for the development of your regulatory submissions and your interactions with FDA.

SCIENCE & TECHNOLOGY... Lachman's Science and Technology Practice offers industry-leading scientific and technical expertise in analyzing and addressing a wide range of scientific, technical, and compliance problems.

ANNOUNCEMENT - March 4, 2014

Frances M. Zipp

is new President, Consulting Operations for Lachman Consultants.

EVENTS - September 23, 2014

FDAnews Webinar:

Impact of GDUFA Performance Metrics on ANDA Approval Times Opportunities, Risks and Practical Considerations